OncoSil Medical Limited

A$0.69As of Sun 8 Nov 2026, 12:00 UTC
ASX:OSLHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (31.65%)
Div yield —
ROE (268.15%)
Medical Devices
Beta (5Y) 1.33
PE TTM —
TSR TTM (45.10%)
Mkt cap A$25.14M
ROIC (168.20%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.773
12.84%
24.46%
Hold 3|11|7|8|2
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.01
0.01
0.01
0.01
7.00%
1.60%
0.10%
1.93%
Revenue$M
2.263
2.330
2.351
2.472
16.10%
13.00%
8.26%
7.44%
Peers (US$17.27M)
Cap (US$)
PE
16.02M
—
17.18M
—
Capital
TTM
5Y
10Y
Leveragex
1.016
0.056
0.055
EBIT/Intx
0.616
0.079
0.075
Own earn%
(43.94)
23.78
18.74
Sh yield%
46.34
17.58
19.12
Owners
Insiders/Inst%
9.46
72.83
Short interest%
3.62
SBC / revenue%
4.00
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
10
Op margin range%
3–7
$1 testx
—
Incr. ROIC%
16